Natesto Alternatives Compared
| Natesto (testosterone) | Testosterone | AndroGel (testosterone) |
|
|---|
| Natesto (testosterone) | Testosterone | AndroGel (testosterone) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Hypogonadism - Male. Natesto may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Hypogonadism - Male, Gender Affirming Hormone Therapy , Gender Dysphoria, Delayed Puberty - Male, Postpartum Breast Pain, Breast Cancer - Palliative, Klinefelter Syndrome. Testosterone... View more |
Prescription only
Prescribed for Hypogonadism - Male. AndroGel may also be used for purposes not listed in this medication guide. |
Related suggestions Hypogonadism, Male
|
|||||||||||||||||||||||
| More about Natesto (testosterone) | More about Testosterone | More about AndroGel (testosterone) | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Natesto has an average rating of 8.0 out of 10 from a total of 6 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 0% reported a negative effect. |
Testosterone has an average rating of 7.2 out of 10 from a total of 531 ratings on Drugs.com. 64% of reviewers reported a positive effect, while 19% reported a negative effect. |
AndroGel has an average rating of 7.4 out of 10 from a total of 111 ratings on Drugs.com. 64% of reviewers reported a positive effect, while 18% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
||||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Natesto prices |
View all Testosterone prices |
View all AndroGel prices |
||||||||||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Other testosterone brands include: Andro LA 200, Andro-Cyp 100, Andro-Cyp 200, Androderm, AndroGel, Aveed, Azmiro, Delatest, Depandro 100, Depo-Testosterone, Depotest, Duratest, Durathate 200, Everone, FIRST-Testosterone, FIRST-Testosterone MC, Fortesta, Histerone, Jatenzo, Kyzatrex, Striant, Testim, Testo-100, Testo-200, Testopel, Testopel Pellets, Testro-LA, Tlando, Undecatrex, Vogelxo, Xyosted View more | Andro LA 200, Andro-Cyp 100, Andro-Cyp 200, Androderm, AndroGel, Aveed, Azmiro, Delatest, Depandro 100, Depo-Testosterone, Depotest, Duratest, Durathate 200, Everone, FIRST-Testosterone, FIRST-Testosterone MC, Fortesta, Histerone, Jatenzo, Kyzatrex, Natesto, Striant, Testim, Testo-100, Testo-200, Testopel, Testopel Pellets, Testro-LA, Tlando, Undecatrex, Vogelxo, Xyosted View more | Other testosterone brands include: Andro LA 200, Andro-Cyp 100, Andro-Cyp 200, Androderm, Aveed, Azmiro, Delatest, Depandro 100, Depo-Testosterone, Depotest, Duratest, Durathate 200, Everone, FIRST-Testosterone, FIRST-Testosterone MC, Fortesta, Histerone, Jatenzo, Kyzatrex, Natesto, Striant, Testim, Testo-100, Testo-200, Testopel, Testopel Pellets, Testro-LA, Tlando, Undecatrex, Vogelxo, Xyosted View more | ||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
2 hours |
2 hours |
2 hours |
||||||||||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
|
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 183 drugs are known to interact with Natesto:
|
A total of 183 drugs are known to interact with Testosterone:
|
A total of 183 drugs are known to interact with AndroGel:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
N/A |
December 24, 1953 |
February 28, 2000 |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.